有研粉材(688456.SH):擬使用6000萬元募集資金向有研重冶增資 用於實施募投項目
格隆匯12月14日丨有研粉材(688456.SH)公佈,公司於2021年12月14日召開第一屆董事會第十七次臨時會議和第一屆監事會第七次臨時會議,審議通過了《關於變更部分募投項目實施主體並向全資子公司增資用於實施募投項目的議案》,同意“有研粉末科技創新中心建設項目”實施主體由北京有研粉末新材料研究院有限公司(粉末研究院)變更為有研粉材,該項目其他內容不變,並同意公司使用6000萬元募集資金向全資子公司重慶有研重冶新材料有限公司(“有研重冶”)增資,用於實施“新建粉體材料基地建設項目”,視項目實施進度安排資金分批撥付。本次增資完成後,有研重冶仍為公司全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.